?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika · USA
Filter & Suche
173 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
173 Unternehmen gefunden • Seite 4 von 7
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Geron Corporation | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | - | - | 3.04 | 2.85 | ▲ 273.49% | ▲ 2.55% | - | - | - | -46.65% | ▲ 4015.96% | -29.28% | ▲ 3932.99% | -60.41% | ▲ 3478.82% | 3 / 9 | −5,84 | −6,5-fach | 31 / 100 | 4,4 / 100 | −1,81 |
 | Evolus Inc | 37.5 | Arzneimittel (Pharmazeutisch) | USA | 0.5 Mrd. USD | - | - | 1.57 | -16.07 | ▲ 39.36% | ▼ -20.54% | - | - | - | -17.38% | ▲ 9.03% | -12.65% | ▲ 9.48% | -17.07% | ▲ 8.66% | 3 / 9 | −8,61 | −2,1-fach | 85 / 100 | −4,2 / 100 | −2,60 |
 | Protagonist Therapeutics Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 9.2 Mrd. USD | 110.94 | 71.15 | 32.62 | 10.93 | ▲ 9.96% | ▲ 14.49% | - | - | - | -282.83% | ▲ 87.98% | -343.63% | ▲ 78.52% | 121.87% | ▲ 149.23% | 5 / 9 | 13,32 | unbegrenzt | 7 / 100 | −28,0 / 100 | −6,83 |
 | CareDx Inc | 36.3 | Arzneimittel (Biotechnologie) | USA | 3.7 Mrd. USD | 33.61 | 43.88 | 8.15 | 8.77 | ▲ 14.59% | ▲ 2.67% | - | - | - | -5.62% | ▲ 4.90% | -6.60% | ▲ 4.31% | 9.51% | ▲ 7.06% | 6 / 9 | −0,60 | - | 62 / 100 | −15,3 / 100 | −3,30 |
 | Arrowhead Pharmaceuticals Inc | 35.4 | Arzneimittel (Biotechnologie) | USA | 8.5 Mrd. USD | - | - | 12.70 | 18.27 | ▲ 56.63% | ▼ -54.60% | - | - | - | -0.20% | ▼ -1660.67% | 11.86% | ▼ -1661.44% | 18.91% | ▼ -1711.65% | 6 / 9 | 1,00 | −4,5-fach | 62 / 100 | −13,4 / 100 | - |
 | Natera Inc | 35.2 | Arzneimittel (Biotechnologie) | USA | 61.2 Mrd. USD | - | 853.28 | 22.60 | 33.59 | ▲ 42.61% | ▼ -1.95% | - | - | - | -9.03% | ▲ 18.83% | -13.44% | ▲ 17.57% | 4.73% | ▲ 19.23% | 6 / 9 | 0,71 | −31,6-fach | 60 / 100 | −16,9 / 100 | 0,41 |
 | Arcturus Therapeutics Holdings Inc | 34.9 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 14.67 | 2.03 | ▲ 47.77% | ▼ -1.83% | - | - | - | -97.86% | ▲ 303.72% | -111.51% | ▲ 298.46% | -110.83% | ▲ 196.34% | 2 / 9 | 1,07 | −224,0-fach | 24 / 100 | 3,1 / 100 | −0,98 |
 | Zymeworks Inc. Common Stock | 34.6 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | - | - | 55.97 | 25.85 | ▲ 22.16% | ▼ -14.79% | - | - | - | -76.56% | ▲ 124.40% | -87.33% | ▲ 123.05% | -32.58% | ▲ 129.71% | 6 / 9 | −3,28 | - | 31 / 100 | −13,9 / 100 | −3,55 |
 | Emergent Biosolutions Inc | 34.2 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | 4.23 | 0.47 | 1.06 | ▼ -13.98% | ▼ -29.68% | - | - | - | 7.08% | ▼ -1.12% | 14.83% | ▼ -0.40% | 21.11% | ▲ 4.82% | 6 / 9 | 3,66 | −2,6-fach | 27 / 100 | −9,0 / 100 | −3,48 |
 | Janux Therapeutics Inc | 33.9 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 34.61 | 1.19 | ▲ 92.33% | ▲ 75.71% | - | - | - | -1136.25% | ▼ -50.49% | -1576.67% | ▼ -149.71% | -832.78% | ▼ -49.45% | 3 / 9 | 24,11 | - | 1 / 100 | −3,1 / 100 | −1,94 |
 | Tarsus Pharmaceuticals Inc | 33.8 | Arzneimittel (Pharmazeutisch) | USA | 3.4 Mrd. USD | - | 54.78 | 5.56 | 9.72 | ▲ 68.30% | ▲ 19.89% | - | - | - | -14.72% | ▲ 19.64% | -15.72% | ▲ 18.82% | -4.94% | ▲ 12.47% | 5 / 9 | 3,03 | −15,1-fach | 75 / 100 | −9,6 / 100 | −1,66 |
 | Amneal Pharmaceuticals, Inc. Class A Common Stock | 33.1 | Arzneimittel (Pharmazeutisch) | USA | 7.4 Mrd. USD | 47.25 | 89.48 | 2.39 | 225.17 | ▲ 8.66% | ▼ -4.57% | - | - | - | 2.39% | ▲ 0.55% | 14.02% | ▲ 2.67% | 8.94% | ▲ 0.84% | 8 / 9 | 2,14 | 1-fach | 32 / 100 | −7,4 / 100 | −2,59 |
 | Viridian Therapeutics Inc | 32.6 | Arzneimittel (Biotechnologie) | USA | 2.8 Mrd. USD | - | - | 38.66 | 4.15 | ▲ 132.18% | ▲ 25.35% | - | - | - | -483.57% | ▼ -7766.47% | -512.91% | ▼ -8708.32% | -390.81% | ▼ -6883.01% | 4 / 9 | 2,91 | −85,4-fach | 8 / 100 | −7,4 / 100 | - |
 | AnaptysBio Inc | 32.5 | Arzneimittel (Biotechnologie) | USA | 1.5 Mrd. USD | 7.71 | 83.71 | 6.35 | 142.63 | ▲ 25.62% | ▼ -7.87% | - | - | - | -5.64% | ▲ 126.39% | 20.42% | ▲ 121.42% | 8.36% | ▲ 73.66% | 6 / 9 | 0,05 | −1,2-fach | 64 / 100 | −9,0 / 100 | −3,44 |
 | Castle Biosciences Inc | 31.3 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 3.14 | 2.38 | ▲ 40.60% | ▲ 18.63% | - | - | - | -7.02% | ▲ 10.70% | -12.44% | ▲ 11.61% | 8.23% | ▲ 10.97% | 4 / 9 | 6,30 | −95,9-fach | 47 / 100 | −15,3 / 100 | −3,50 |
 | Tango Therapeutics Inc | 31.0 | Arzneimittel (Biotechnologie) | USA | 3.8 Mrd. USD | - | - | 56.36 | 23.42 | ▲ 52.13% | ▲ 14.35% | - | - | - | -162.85% | ▲ 11.41% | -178.39% | ▲ 5.81% | -224.31% | ▲ 3.80% | 4 / 9 | 5,74 | - | 15 / 100 | 9,4 / 100 | - |
 | Legend Biotech Corp | 30.4 | Arzneimittel (Biotechnologie) | USA | 4.4 Mrd. USD | - | - | 3.45 | 3.56 | ▲ 68.83% | ▲ 2.19% | - | - | - | -28.85% | ▲ 141.78% | -13.27% | ▲ 145.45% | -16.33% | ▲ 84.18% | 3 / 9 | −0,95 | −13,8-fach | 36 / 100 | −11,3 / 100 | −2,70 |
 | Nurix Therapeutics Inc | 30.4 | Arzneimittel (Biotechnologie) | USA | 3.0 Mrd. USD | 10.10 | 8.05 | 4.24 | 3.08 | ▲ 36.35% | ▲ 43.64% | - | - | - | -314.90% | ▲ 23.31% | -340.16% | ▲ 19.77% | -313.73% | ▲ 8.98% | 5 / 9 | 1,42 | - | 9 / 100 | −2,2 / 100 | −5,12 |
 | Relay Therapeutics Inc | 29.4 | Arzneimittel (Biotechnologie) | USA | 4.3 Mrd. USD | - | - | 416.90 | 4.85 | ▼ -28.58% | ▲ 39.46% | - | - | - | -1800.58% | ▲ 3808.61% | -1971.59% | ▲ 3808.61% | -1536.08% | ▲ 1683.43% | 6 / 9 | 3,25 | - | 2 / 100 | −6,6 / 100 | - |
 | Twist Bioscience Corp | 29.4 | Arzneimittel (Biotechnologie) | USA | 11.5 Mrd. USD | - | - | 26.63 | 25.80 | ▲ 33.11% | ▼ -11.11% | - | - | - | -20.63% | ▲ 22.90% | -36.18% | ▲ 21.02% | -20.08% | ▲ 25.94% | 5 / 9 | −2,10 | −14.369,1-fach | 30 / 100 | −4,7 / 100 | −2,14 |
 | Cytokinetics Inc | 28.9 | Arzneimittel (Biotechnologie) | USA | 8.5 Mrd. USD | - | - | 120.06 | -49.11 | ▲ 9.54% | ▲ 43.88% | - | - | - | -891.60% | ▼ -395.17% | -695.44% | ▼ -342.18% | -607.48% | ▼ -250.69% | 5 / 9 | −8,23 | −6,7-fach | 5 / 100 | −19,3 / 100 | −3,30 |
 | Arbutus Biopharma Corp | 28.7 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 4.33 | - | 3.64 | 2.56 | ▲ 15.29% | ▼ -12.07% | - | - | - | -237.88% | ▼ -4.30% | -192.08% | ▼ -11.49% | -281.45% | ▼ -28.09% | 4 / 9 | −39,33 | −253,4-fach | 14 / 100 | 6,5 / 100 | 0,28 |
 | Iovance Biotherapeutics Inc | 28.4 | Arzneimittel (Biotechnologie) | USA | 6.7 Mrd. USD | - | - | 20.64 | 9.11 | - | - | - | - | - | -148.38% | - | -151.12% | - | -127.61% | - | 5 / 9 | −7,20 | - | 10 / 100 | −9,7 / 100 | −2,96 |
 | CG Oncology, Inc. Common stock | 28.1 | Arzneimittel (Biotechnologie) | USA | 5.7 Mrd. USD | - | - | 910.31 | 5.51 | - | - | - | - | - | -3985.02% | ▲ 310.49% | -4722.13% | ▼ -81.47% | -3279.21% | ▲ 238.74% | 4 / 9 | 23,38 | −42,1-fach | −0 / 100 | −3,6 / 100 | 2,50 |
 | Aktis Oncology, Inc. Common stock | 28.1 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | - | - | 92.99 | 1.93 | ▲ 35.11% | ▲ 15.59% | - | - | - | -980.93% | ▲ 3.24% | -1149.52% | ▼ -182.52% | -1134.54% | ▲ 249.85% | 3 / 9 | 1,01 | −26,4-fach | 2 / 100 | 0,2 / 100 | −0,20 |
USA